Bank of New York Mellon Corp - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,651,411
-33.4%
329,847
-2.5%
0.00%0.0%
Q2 2023$5,481,193
+132.2%
338,137
+138.5%
0.00%0.0%
Q1 2023$2,360,455
+58.6%
141,769
-10.4%
0.00%
Q4 2022$1,487,888
+423.9%
158,286
+52.0%
0.00%
Q3 2022$284,000
-7.2%
104,144
-1.6%
0.00%
Q2 2022$306,000
-68.7%
105,784
-67.5%
0.00%
Q1 2022$977,000
-17.7%
325,748
+26.3%
0.00%
Q4 2021$1,187,000
-29.0%
257,913
-3.2%
0.00%
Q3 2021$1,673,000
+11.6%
266,352
+6.5%
0.00%
Q2 2021$1,499,000
-20.8%
250,161
-16.4%
0.00%
Q1 2021$1,893,000
+12.1%
299,281
-0.2%
0.00%
Q4 2020$1,688,000
-7.0%
299,777
-3.9%
0.00%
Q3 2020$1,816,000
-20.0%
312,036
-0.8%
0.00%
-100.0%
Q2 2020$2,269,000
+53.8%
314,682
-0.2%
0.00%
Q1 2020$1,475,000
-40.9%
315,168
+1.2%
0.00%
-100.0%
Q4 2019$2,497,000
+26.8%
311,293
+8.7%
0.00%0.0%
Q3 2019$1,970,000
-35.7%
286,330
-22.4%
0.00%0.0%
Q2 2019$3,063,000
-3.7%
369,002
+15.3%
0.00%0.0%
Q1 2019$3,181,000
+7.5%
319,975
-17.3%
0.00%0.0%
Q4 2018$2,960,000
-55.9%
387,039
+0.4%
0.00%
-50.0%
Q3 2018$6,714,000
+104.4%
385,484
+11.4%
0.00%
+100.0%
Q2 2018$3,284,000
+2885.5%
346,029
+1267.8%
0.00%
Q1 2018$110,00025,2980.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders